Latest News & Updates

Breaking News

  • 14 hours ago

  • Vaibhavi M.

Medix Biochemica Appoints Petra Furu As Chief Executive Officer To Lead Next Growth Phase
Breaking News
Dogwood Therapeutics Secures FDA IND Approval For SP16 in Neuropathy Treatment

Vaibhavi M.

Other trending news you may like to read

Medix Biochemica Appoints Petra Furu As Chief Executive Officer To Lead Next Growth Phase

Medix Biochemica appoints Petra Furu as CEO to lead growth strategy, strengthen IVD business operations, and drive expansion across global diagnostics markets.

Vaibhavi M.

Pharma Now

Dogwood Therapeutics Secures FDA IND Approval For SP16 in Neuropathy Treatment

Dogwood Therapeutics secures FDA IND approval for SP16 to treat chemotherapy-induced peripheral neuropathy, enabling Phase 1b trial initiation in 2026.

Vaibhavi M.

Pharma Now

Achieve Advanced Cytisinicline Manufacturing, Targets NDA Resubmission In 2026

Achieve Life Sciences advances cytisinicline manufacturing with Adare and targets NDA resubmission in 2026 for nicotine dependence treatment following FDA review timeline.

Vaibhavi M.

Pharma Now

Plus Therapeutics Appoints Randy Goodman As Vice President To Lead HEOR And Market Access Strategy

Plus Therapeutics appoints Randy Goodman as VP HEOR to lead value strategy, pricing, and market access for CNSide and REYOBIQ in its CNS oncology pipeline development.

Vaibhavi M.

Pharma Now